Cigna Group (CI), recognized as a giant in the healthcare market, has been trading below its true value. After the declaration of a new $1.51 quarterly dividend, financial analysis points to a strong buy rating with a potential upside of 22.46%. The dividend, payable on the record date of Dec 4, led to a 3.1% jump in stock price. The company's stock suffered a 10% plunge due to disappointing earnings but Wells Fargo has raised its price target to $354. In a recent leadership reshuffle to foster growth, the company's COO sold stocks worth $1.61M. Despite showing strong Q2 results and adjusted EPS, the firm lags in earnings growth compared to a five-year shareholder return. Cigna group recently sold its Medicare businesses to HCSC and expanded their AI imaging coverage, driving innovation in healthcare. In partnership with community organizations, the company's foundation improved 34,000 lives through increased youth mental health support. The Q2 2025 earnings are expected to be promising with analysts forecasting a buy given their strong revenue and raised EPS guidance.
The Cigna Group CI News Analytics from Tue, 14 Jan 2025 08:00:00 GMT to Sat, 25 Oct 2025 13:30:27 GMT -
Rating 7
- Innovation 5
- Information 8
- Rumor 2
